Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03180073 · ClinicalTrials.gov registry record
Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 100
- Enrollment target
NCT03180073 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 100 participants.
The verdict
NCT03180073 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Most of the conduction abnormalities with TAVR are usually detected during the procedure or during the following days of observation. Little is known about the prevalence and timing of any conduction abnormalities that exist before (other than standard ECG) or after through long term cardiac monitoring.
Interventions
- DIAGNOSTIC_TEST Ziopatch Pre discharge
- DIAGNOSTIC_TEST Ziopatch at Discharge
- DIAGNOSTIC_TEST Ziopatch at 2 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2020-12-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03180073
The ClinicalTrials.gov registry entry for NCT03180073 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ziopatch Pre discharge is the first listed.
NCT03180073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03180073 about?
NCT03180073 is a clinical study titled "Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement". Most of the conduction abnormalities with TAVR are usually detected during the procedure or during the following days of observation. Little is known about the prevalence and timing of any conduction abnormalities that exist before (other than standard ECG) or after through long term cardiac monitor...
What is the current status of trial NCT03180073?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-06-06. Estimated completion is 2020-12-23.
What interventions are being tested in trial NCT03180073?
The interventions under investigation include: Ziopatch Pre discharge (DIAGNOSTIC_TEST), Ziopatch at Discharge (DIAGNOSTIC_TEST), Ziopatch at 2 months (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03180073?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.